SCHEMBL7842833

SCHEMBL7842833

Cc1cccc(C2CCN(C(=O)OC(C)(C)C)C[C@H]2O)c1

nearest known ligand 0.56

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 4/20 0.56
JAK2 O60674 1/20 0.49
JAK3 P52333 1/20 0.49
PTK2 Q05397 1/20 0.49
TACR1 P25103 1/20 0.46
GRM5 P41594 1/20 0.44
KMT2A Q03164 4/20 0.43
MEN1 O00255 3/20 0.43
USP30 Q70CQ3 3/20 0.43
STS P08842 1/20 0.43
PDE4B Q07343 1/20 0.43
RORC P51449 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7841659 1.00 GPR119 (0.56) GPR119JAK2JAK3PTK2TACR1
SCHEMBL7841657 1.00 GPR119 (0.56) GPR119JAK2JAK3PTK2TACR1
SCHEMBL528604 0.87 GPR119 (0.55) GPR119TACR1GRM5KMT2AMEN1
SCHEMBL18618133 0.87 STS (0.52) GPR119JAK2JAK3PTK2TACR1
SCHEMBL2640450 0.87 JAK2 (0.48) GPR119JAK2JAK3PTK2TACR1
SCHEMBL2640452 0.87 JAK2 (0.48) GPR119JAK2JAK3PTK2TACR1
SCHEMBL2807246 0.87 JAK2 (0.48) GPR119JAK2JAK3PTK2TACR1
SCHEMBL2807244 0.87 JAK2 (0.48) GPR119JAK2JAK3PTK2TACR1
SCHEMBL2242108 0.87 GPR119 (0.54) GPR119JAK2JAK3PTK2TACR1
SCHEMBL407256 0.87 GPR119 (0.54) GPR119JAK2JAK3PTK2TACR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0944388-A4 INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE MERCK & CO INC (US) 2001-08-16 EP disclosed
EP-0944388-A2 INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE Merck & Co., Inc. (US) 1999-09-29 EP disclosed
WO-1997038665-A2 INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE MERCK & CO., INC. (US) 1997-10-23 WO disclosed